ストックスクリーナーアプリを入手
46.61
4.31%
-2.10
Anaptysbio Inc (ANAB) 最新ニュース
After an $18.03-per-share option exercise, AnaptysBio (ANAB) director sells 5,000 shares. - Stock Titan
Director Hollings C. Renton plans to sell 5,000 AnaptysBio (ANAB) shares valued at about $249K. - Stock Titan
Latigo Biotherapeutics, Inc. Common Stock (LTGO) Earnings Reports & Dates - FXEmpire
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates - Zacks Investment Research
Spin-off leaves AnaptysBio (ANAB) a lean royalty firm - Stock Titan
AnaptysBio (ANAB) director adds shares as RSUs vest - Stock Titan
AnaptysBio earnings on deck: Jemperli lawsuit takes center stage By Investing.com - Investing.com Australia
AnaptysBio earnings on deck: Jemperli lawsuit takes center stage By Investing.com - Investing.com Canada
AnaptysBio earnings on deck: Jemperli lawsuit takes center stage - investing.com
ANAB Q2'26 Earnings: EPS estimate is (0.47) USD - TradingView
Alphyn Capital on Its Special-Situation Investment: AnaptysBio (ANAB) - Yahoo Finance UK
Squarepoint Ops LLC Has $21.90 Million Position in AnaptysBio, Inc. $ANAB - MarketBeat
AnaptysBio, Inc. $ANAB Shares Purchased by Hsbc Holdings PLC - MarketBeat
U.S. Earnings Preview: After Market Close Sept. 8 - moomoo.com
Irenic Capital Management LP Makes New Investment in AnaptysBio, Inc. $ANAB - MarketBeat
Bank of New York Mellon Corp Makes New $3.81 Million Investment in AnaptysBio, Inc. $ANAB - marketbeat.com
ANAB Q2'26 Earnings: revenue estimate is 8.89M USD - TradingView
Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
U.S. Earnings Preview: After Market Close Sept. 1 - Moomoo
AnaptysBio stock rating maintained at Outperform by Wolfe Research - Investing.com Nigeria
AnaptysBio stock rating maintained at Outperform by Wolfe Research - Investing.com
AnaptysBio stock rating maintained at Outperform by Wolfe Research - Investing.com India
AnaptysBio earnings on deck: Can Jemperli offset revenue slide? By Investing.com - Investing.com Australia
AnaptysBio earnings on deck: Can Jemperli offset revenue slide? By Investing.com - Investing.com Canada
AnaptysBio earnings on deck: Can Jemperli offset revenue slide? By Investing.com - Investing.com South Africa
AnaptysBio earnings on deck: Can Jemperli offset revenue slide? - Investing.com
AnaptysBio earnings on deck: Can Jemperli offset revenue slide? By Investing.com - Investing.com India
AnaptysBio earnings on deck: Can Jemperli offset revenue slide? By Investing.com - Investing.com UK
Empowered Funds LLC Makes New $13.91 Million Investment in AnaptysBio, Inc. $ANAB - MarketBeat
1,844,049 Shares in AnaptysBio, Inc. $ANAB Bought by BlackRock Inc. - marketbeat.com
AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
AnaptysBio Inc. (ANAB) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Palo Alto Investors LP Purchases Shares of 603,489 AnaptysBio, Inc. $ANAB - MarketBeat
Hsbc Holdings PLC Purchases Shares of 216,949 AnaptysBio, Inc. $ANAB - MarketBeat
Deutsche Bank AG Makes New Investment in AnaptysBio, Inc. $ANAB - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Takes Position in AnaptysBio, Inc. $ANAB - MarketBeat
ANAB Maintained by TD Cowen -- Price Target Lowered to $70 - GuruFocus
TD Cowen lowers Anaptysbio stock price target to $70 on FDA review - Investing.com UK
TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating - Moomoo
TD Cowen lowers Anaptysbio stock price target to $70 on FDA review - Investing.com India
AnaptysBio, Inc. (ANAB) Earnings Preview: The First Full Royalty-Model Quarter Matters More Than the Headline EPS - AlphaStreet
TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $70 - Moomoo
AnaptysBio (NASDAQ:ANAB) Given Buy Rating at HC Wainwright - MarketBeat
Greenhaven Road Investment Management, L.P.'s AnaptysBio Inc(ANAB) Holding History - GuruFocus
AnaptysBio (NASDAQ:ANAB): High Growth Momentum Aligns With a Breakout Setup - ChartMill
U.S. Earnings Preview: After Market Close Aug. 18 - Moomoo
US High Growth Tech Stocks To Watch In August 2026 - simplywall.st
US High Growth Tech Stocks To Watch In August 2026 - simplywall.st
GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Control - Yahoo Finance
7.53%
4.63%
大文字化:
|
ボリューム (24 時間):